These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1484266)

  • 1. Clonal patterns in the human immune response to HIV-1 infection.
    Müller S; Nara P; D'Amelio R; Biselli R; Gold D; Wang H; Köhler H; Silverman GJ
    Int Rev Immunol; 1992; 9(1):1-13. PubMed ID: 1484266
    [No Abstract]   [Full Text] [Related]  

  • 2. B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.
    Cagigi A; Nilsson A; De Milito A; Chiodi F
    Vaccine; 2008 Jun; 26(24):3016-25. PubMed ID: 18164520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody response in HIV-1 infection.
    Burton DR; Montefiori DC
    AIDS; 1997; 11 Suppl A():S87-98. PubMed ID: 9451972
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody convergence along a common idiotypic axis in immunodeficiency virus and hepatitis C virus infections.
    Grant MD
    J Med Virol; 2002 Jan; 66(1):13-21. PubMed ID: 11748653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?
    Parsons MS; Muller S; Kohler H; Grant MD; Bernard NF
    Hum Vaccin Immunother; 2013 Jul; 9(7):1532-8. PubMed ID: 23571168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of human anti-HIV broadly neutralizing antibodies occurs within the context of frozen 1F7-idiotypic repertoire.
    Parsons MS; Rouleau D; Routy JP; LeBlanc R; Grant MD; Bernard NF
    AIDS; 2011 Jun; 25(10):1249-64. PubMed ID: 21516028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quest for an antibody-based HIV vaccine.
    Haynes BF; Mascola JR
    Immunol Rev; 2017 Jan; 275(1):5-10. PubMed ID: 28133795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell activation and HIV-1 infection: deeds and misdeeds.
    Amadori A; Chieco-Bianchi L
    Immunol Today; 1990 Oct; 11(10):374-9. PubMed ID: 2103733
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum antibody directed against synthetic peptides derived from HIV-1 protein sequence obtained from 26 Japanese HIV-1-infected individuals.
    Inami S; Taniguchi N; Ishibashi K; Nagao T; Aoki I; Ishii N; Okuda K
    AIDS; 1991 Sep; 5(9):1140-1. PubMed ID: 1930779
    [No Abstract]   [Full Text] [Related]  

  • 10. B cell activation and HIV infection: protective or potentially detrimental response?
    Amadori A; Chieco-Bianchi L
    Int Rev Immunol; 1992; 9(1):15-24. PubMed ID: 1484267
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlating low-similarity peptide sequences and HIV B-cell epitopes.
    Kanduc D; Serpico R; Lucchese A; Shoenfeld Y
    Autoimmun Rev; 2008 Feb; 7(4):291-6. PubMed ID: 18295732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored immunogens for rationally designed antibody-based HIV-1 vaccines.
    Mouquet H
    Trends Immunol; 2015 Aug; 36(8):437-9. PubMed ID: 26169255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus (HIV) circulating immune complexes in infected children.
    Ellaurie M; Calvelli TA; Rubinstein A
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1437-41. PubMed ID: 1981834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody polyspecificity and neutralization of HIV-1: a hypothesis.
    Haynes BF; Moody MA; Verkoczy L; Kelsoe G; Alam SM
    Hum Antibodies; 2005; 14(3-4):59-67. PubMed ID: 16720975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 evolution and disease progression.
    Nowak MA; Anderson RM; Boerlijst MC; Bonhoeffer S; May RM; McMichael AJ
    Science; 1996 Nov; 274(5289):1008-11. PubMed ID: 8966557
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonrandom features of the human immunoglobulin variable region gene repertoire expressed in response to HIV-1.
    Zouali M
    Appl Biochem Biotechnol; 1996; 61(1-2):149-55. PubMed ID: 9100352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy.
    Morris L; Binley JM; Clas BA; Bonhoeffer S; Astill TP; Kost R; Hurley A; Cao Y; Markowitz M; Ho DD; Moore JP
    J Exp Med; 1998 Jul; 188(2):233-45. PubMed ID: 9670036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody and B-cell responses may control circulating lipopolysaccharide in patients with HIV infection.
    Lim A; Amini A; D'Orsogna LJ; Rajasuriar R; Kramski M; Lewin SR; Purcell DF; Price P; French MA
    AIDS; 2011 Jul; 25(11):1379-83. PubMed ID: 21572302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B lymphocyte-derived humoral immune defenses in breast milk transmission of the HIV-1.
    Bélec L; Kourtis AP
    Adv Exp Med Biol; 2012; 743():139-60. PubMed ID: 22454347
    [No Abstract]   [Full Text] [Related]  

  • 20. A conserved idiotype and antibodies to retroviral proteins in systemic lupus erythematosus.
    Talal N; Garry RF; Schur PH; Alexander S; Dauphinée MJ; Livas IH; Ballester A; Takei M; Dang H
    J Clin Invest; 1990 Jun; 85(6):1866-71. PubMed ID: 2112156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.